Ligand validation:6ARB

PYR: PYRUVIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6ARB_PYR_C_302	69%	7%	0.121	0.934	2.78	2.07	3	2	0	0	100%	1
6ARB_PYR_A_302	55%	6%	0.131	0.897	2.84	2.25	3	2	0	0	100%	1
6ARB_PYR_B_302	51%	7%	0.148	0.902	2.82	1.98	3	2	0	0	100%	1
6AQ4_PYR_C_302	75%	7%	0.137	0.972	2.67	2.24	3	2	0	0	100%	1
6CJ3_PYR_A_305	60%	6%	0.143	0.927	2.77	2.19	3	2	0	0	100%	0.88
2O9A_PYR_C_907	100%	2%	0.038	0.982	4.39	2.62	2	2	0	0	100%	1
4RV5_PYR_B_501	99%	17%	0.052	0.982	2.44	1.18	3	-	0	0	100%	1
5CM6_PYR_A_401	98%	11%	0.059	0.985	2.5	1.7	3	1	0	0	100%	1
3R75_PYR_B_702	98%	29%	0.062	0.987	1.5	1.32	1	1	0	0	100%	1
1WA3_PYR_A_1204	98%	21%	0.061	0.984	2.06	1.26	1	-	0	0	100%	0.8333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.